Donald Williams Parsons, M.D., Ph.D.

Associate Professor
Baylor College of Medicine

Planning Committee Member

Past

QA Presentations (February 10, 2021)

February 10, 2021, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

"A Teenager with a High-Grade Optic Pathway Tumor with a High Tumor Mutation Burden" and "A School-Age Child with High-Grade Glioma with a High Tumor Mutation Burden"

December 9, 2020, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

Acute Myeloid Leukemia with a Germline CEBPA Variant

January 13, 2021, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

"Retroperitoneal Tumor with NTRK1 Fusion in a Toddler" and "Pleuropulmonary Blastoma with a DICER1 Mutation in a Toddler"

November 11, 2020, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (June 10, 2021)

June 10, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (June 17, 2021)

June 17, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (June 24, 2021)

June 24, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Genomic Alterations Informing Treatment of Vascular Tumors

August 10, 2022, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

Leveraging Mouse Models of Pediatric High-Grade Glioma to Investigate Genetic Drivers and Microenvironment Interactions

April 8, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Dissecting the Sickle Cell Disease Phenotype through International Collaborative Research Studies

October 21, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Molecular Diagnosis of Low-Grade Brain Tumors

September 14, 2022, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

Anaplastic Lymphoma Kinase Fusion

October 12, 2022, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

Management of Thyroid Cancer in Children

December 14, 2022, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

Two Cases of Anaplastic Ganglioglioma with Distinct Molecular Drivers

January 11, 2023, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

Quality Assurance Presentation: Complexities of CEBPA in Pediatric Acute Myeloid Leukemia

February 8, 2023, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

Mesenchymal Tumors with CREB::CREM Fusion

April 10, 2024, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

Theme: Results from the Molecular Characterization Initiative (MCI)

June 14, 2023, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

QA Presentations (March 10, 2021)

March 10, 2021, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

Improving Access to Care in Sickle Cell Disease

April 15, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

BiTES and ADCs in Childhood Acute Lymphocytic Leukemia: Issues and Directions (The Alphabet Soup of Pediatric Leukemia)

May 20, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series and The Donald J. Fernbach Distinguished Lectureship Seminar Series

1 hr

Credit

Past

Improving the Management of Cancer Risks in Children with Hereditary Cancer Predisposition Syndromes

March 25, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Are We Learning from Our Cancer Survivors?

April 1, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (September 26, 2024)

September 26, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

CIC-Rearranged Sarcoma

February 14, 2024, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

Pediatric Acute Leukemia with ETV6 Alterations

August 9, 2023, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

Novel Immunotherapy Approaches for Neuroblastoma

April 29, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Chimeric Antigen Receptor T Cells: Beyond CD19

May 6, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (October 3, 2024)

October 3, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (October 10, 2024)

October 10, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (October 17, 2024)

October 17, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (October 24, 2024)

October 24, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (October 31, 2024)

October 31, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (November 7, 2024)

November 7, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (November 14, 2024)

November 14, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (November 21, 2024)

November 21, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (November 28, 2024)

November 28, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (December 5, 2024)

December 5, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

QA Presentations (May 12, 2021)

May 12, 2021, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (December 12, 2024)

December 12, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Management Consideration for a Toddler with Li Fraumeni Syndrome and Rhabdomyosarcoma

April 12, 2023, 12:00 p.m.

Texas Children's Cancer Center Genomics Tumor Board Series

1 hr

Credit

Past

Bridging the Disparity Gap for Burkitt Lymphoma in Africa

May 27, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (June 3, 2021)

June 3, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (June 20, 2024)

June 20, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Genetic and Molecular Determinants of Hepatoblastoma: Risks and Outcomes

November 3, 2022, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series and The Donald J. Fernbach Distinguished Lectureship Seminar Series

1 hr

Credit

Past

Advancing Equity Research in Pediatric Oncology and Diversifying the Healthcare Workforce

October 20, 2022, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Treatment-Related Cardiotoxicity in Pediatric Acute Myeloid Leukemia

January 12, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Sickle Cell Disease in the Emergency Department: We Must Do Better, and We Will

November 17, 2022, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Barriers and Opportunities for Immunotherapy in Acute Myeloid Leukemia

September 15, 2022, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Recurrent Thrombosis in Children: Who Is at Risk and Can We Prevent Recurrence?

April 13, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Decoding Origin and Oncogenesis in Malignant Brain Cancer

April 20, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Therapeutic Development in Childhood Acute Myeloid Leukemia

March 23, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Methotrexate Pharmacokinetics and Pharmacogenetics: From Discovery Through Implementation

February 2, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Thinking Beyond Vaso-Occlusion to Identify the Etiologies of Pain in Sickle Cell Disease

February 9, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Toward the Implementation of Precision Medicine in Hepatoblastoma

February 16, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Clonal Hematopoiesis: A Window into Immune Pathogenesis of Aplastic Anemia

February 23, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series and The Donald J. Fernbach Distinguished Lectureship Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (February 23, 2023)

February 23, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Looking into the Future: Reproductive Health in Sickle Cell Disease

March 2, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

The Molecular Basis for Leukemia in Children with Down Syndrome

April 27, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Improving Cognitive Outcomes for Children Treated for Cancer: Moving Beyond the Cure

May 4, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Understanding Clonal Evolution in Recurrent Medulloblastoma: In vivo Modeling and Cancer-Selective Drug Discovery and Design

May 18, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

The Shifting Paradigms of Treatment for Hemophilia

October 5, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Shared Decision-Making for Hemophilia

October 12, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (November 2, 2023)

November 2, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Genetic, Epigenetic, and Functional Heterogeneity in Brain Tumors (November 9, 2023)

November 9, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Tackling Rare: Overcoming Challenges in Histiocytosis

November 30, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Opportunities to Improve Health, Quality of Life, and Survival for Adolescents and Young Adults with Cancer

December 7, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Opportunities for Optimizing Care in Pediatric Thyroid Cancer

January 4, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (January 18, 2024)

January 18, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

The Ogilvie Lab: Studying Central Regulators of Cell Fate Decisions in Medulloblastoma

May 2, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Using Proteomics to Select Therapy in Acute Myelogenous Leukemia

April 11, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Deciphering the Cell Intrinsic and Extrinsic Mechanisms of ZFTA Fusion Driven Ependymoma

February 8, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Acute Myeloid Leukemia: Recent Progress and New Approaches

January 11, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Hijacking of RNA Condensates Corrupts Hematopoietic Cell Identity and Promotes Oncogenesis

May 30, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Transcriptional Heterogeneity Reveals Novel Therapeutic Vulnerabilities in Pediatric Acute Lymphoblastic Leukemia

January 28, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Functional Characterization of Children with Pulmonary Embolism: Rationale, Design, and Preliminary Findings

February 29, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series and The Donald J. Fernbach Distinguished Lectureship Seminar Series

1 hr

Credit

Past

Immunotherapy in Osteosarcoma: Checkpoints and Emerging Approaches

February 22, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series and The Donald J. Fernbach Distinguished Lectureship Seminar Series

1 hr

Credit

Past

Genome Editing of Stem Cells to Create Medicines

November 19, 2020, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Environmental Modifiers of Sickle Disease Severity

December 10, 2020, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Realistic Reflections on the Impact of Race in Research

December 17, 2020, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Navigating Germline Implications of Clinical Tumor Testing

January 14, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Genomic Instability, Metastatic Progression, and Therapy Response in Osteosarcoma

January 7, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series and The Donald J. Fernbach Distinguished Lectureship Seminar Series

1 hr

Credit

Past

Versatile Vimentin: Recombinant Vimentin and Its Rod Domain Blocks Leukocyte Adhesion and SARS-CoV-2 Replication

January 21, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

A Story About OTX2 and Cell Fate Decisions: Exploring the Regulatory Landscape of Medulloblastoma Stem Cells

December 8, 2022, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Transdisciplinary Efforts to Prevent Heart Disease after Cancer

February 4, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Improved Survival for Relapsed Pediatric Acute Lymphocytic Leukemia with Immunotherapy

February 11, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Iron Overload: The Short and the Long-Short of It

February 25, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series and The Donald J. Fernbach Distinguished Lectureship Seminar Series

1 hr

Credit

Past

Neuron-Glial Interactions in Health and Disease: From Cognition to Cancer

March 4, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Precision Medicine for Pediatric Acute Leukemia

March 11, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Precision Oncology for Bone Sarcomas

March 30, 2023, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Inflammatory Caspases and Sickle Cell Disease

September 23, 2021, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Improving Outcomes in Pediatric Leukemia with Big Data

January 6, 2022, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Immune Thrombocytopenia: The Never-Ending Enigma

January 27, 2022, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (April 18, 2024)

April 18, 2024, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Reference Ranges and Health Inequity in Hematology

April 28, 2022, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Developing an Off-the-shelf T-cell Therapy to Treat Patients with CD30+ Lymphoma

December 1, 2022, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Defining the Role of Chromatin Structure in the Evolution from Transient Abnormal Myelopoiesis to Acute Megakaryoblastic Leukemia

June 23, 2022, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (June 16, 2022)

June 16, 2022, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

The Molecular Taxonomy of Human Disease and Targeted Therapeutics

September 29, 2022, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Pediatric Hematology-Oncology Research Seminar Series (June 30, 2022)

June 30, 2022, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

New Strategies Treating T-cell Acute Lymphoblastic Leukemia and Lymphoma

October 13, 2022, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit

Past

Miles to Go Before We Sleep: Moving Toward Novel Therapies for High Risk Medulloblastoma

October 6, 2022, 8:00 a.m.

Pediatric Hematology-Oncology Research Seminar Series

1 hr

Credit